Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

    Published: June 17, 2020 | Price: $6,000.00 – $12,000.00

    Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes.   Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...
    Emerging Infectious Disease Diagnostics: Markets and Trends

    Published: May 27, 2020 | Price: $3,000.00 – $6,000.00

    In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away.  Where could the next pandemic or epidemic come from?   There are a number of diseases currently tracking as moving from the developed world to the developing world? Kalorama has addressed emerging infectious disease since our first study nine...
    Hematology and Coagulation Markets (Lab-based and Decentralized Markets)

    Published: May 19, 2020 | Price: $5,000.00 – $10,000.00

    Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...
    Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets

    Published: May 14, 2020 | Price: $4,000.00 – $8,000.00

    CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...
    Outsourcing in Drug Discovery, 9th Edition

    Published: May 8, 2020 | Price: $5,500.00 – $11,000.00

    Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery has evolved from providing low-end research services to more value-added high-end research. Outsourcing in Drug Discovery provides...
    Cell Therapy and Gene Therapy Markets

    Published: April 27, 2020 | Price: $5,500.00 – $11,000.00

    What is the Size of the Cell and Gene Therapy Market? According to the latest report on the cell and gene therapy market from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3,866 million And most of the market is for the treatment of cancer. Dermatological, Cardiovascular – Blood, Oncology, Ophthalmic, Musculoskeletal and other conditions. With the COVID-19 crisis, there are some efforts to adapt this promising technology to the treatment and...
    Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline

    Published: April 21, 2020 | Price: $4,000.00 – $8,000.00

    The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands currently, this report examines the market for human vaccines used to prevent various types of disease, focusing on commercialized vaccines and...
    Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas

    Published: April 7, 2020 | Price: $750.00 – $1,000.00

    For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...
    Artificial Intelligence Markets in IVD

    Published: April 7, 2020 | Price: $4,000.00 – $8,000.00

    The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care. The goal is to use developed algorithms to standardize and aid interpretation of...
    The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, Cancer Point of Care, Rapid Coagulation, Urine Testing, Lipids, Pregnancy, Glucose and Other Tests)

    Published: March 17, 2020 | Price: $5,500.00 – $11,000.00

    This report represents the 7th edition of a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to...
    The Market and Future Potential for Molecular Point of Care

    Published: March 11, 2020 | Price: $4,000.00 – $8,000.00

    THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/   This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...
    Molecular Cancer Diagnostics Market

    Published: February 12, 2020 | Price: $5,500.00 – $11,000.00

    The potential of molecular diagnostic tools was initially recognized by onco-hematologists during the 1980s based on the observation that specific chromosomal translocations may significantly aid the diagnosis of various types of leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer molecular diagnostics. PCR is the initial step used in isolating and amplifying specific regions of...
    Worldwide Wound Care Market Summary

    Published: January 30, 2020 | Price: $3,500.00 – $7,000.00

    Wound care is very much a challenge for both patients and healthcare providers. The wound care market is a technologically enriched environment dedicated to advancing wound care therapies. Kalorama Information's report, Worldwide Wound Care Market Summary, identifies market opportunity for major sectors of this important market. A particular focus is given to biotechnology used in wound care, including advanced biodressings and negative pressure wound systems. Market data in the report include: World Market Total Worldwide Wound Care Market Revenues 2019-2024...
    Clinical Laboratory Services Market, 5th Edition

    Published: January 27, 2020 | Price: $4,750.00 – $9,500.00

    Clinical laboratories are an essential part of the health industry. The market for laboratory services ranges from routine blood work to esoteric laboratory-developed tests (LDTs). In addition to diagnosing patients, clinical lab testing may be performed to evaluate disease progression, to monitor drug treatment and conditions, and to determine individual therapy. Kalorama’s Clinical Laboratory Services Market, 5th Edition, examines the world and regional markets and is essential for laboratory and IVD companies seeking to better understand the market potential. The...
    NASH Drug Pipeline and Market Overview

    Published: January 6, 2020 | Price: $2,000.00 – $4,000.00

    Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment of this disease in terms of developer, type of drug, phase study, and market entrance estimate....
    CAR-T Cell Therapy Market Review

    Published: December 19, 2019 | Price: $4,000.00 – $8,000.00

    CAR-T cell therapy is a form of immunotherapy that utilizes the body’s own T cells to target and destroy cancer cells. This therapy is a personalized form of treatment, meaning that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from a patient and having them grown and modified in a lab. These new T cells are given a gene for a specialized receptor, known as...
    Exome Sequencing Market

    Published: November 25, 2019 | Price: $4,000.00 – $8,000.00

    The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing – despite price declines – has led to demands for more efficient methods. Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual's DNA that provide instructions for making proteins are sequenced. These pieces, called exons, are thought to make up roughly 2 percent of a...
    Blockchain Technologies in Healthcare

    Published: November 22, 2019 | Price: $2,000.00 – $4,000.00

    Blockchain is essentially a tool that has the potential to keep secure data in a distributed ledger with the capability to be shared across networks. The concept behind blockchain is that it has three components: a widely distributed network a shared ledger with validated access identities digital transactions Blockchain technology is emerging in many other industries but it has some unique challenges in healthcare. Blockchain Technologies in Healthcare discusses some of the major application areas for blockchain technology in healthcare:...
    Current IVD Market Trends

    Published: October 31, 2019 | Price: $3,000.00 – $6,000.00

    This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...
    The Global Market for Medical Devices, 10th Edition (45 Specific Device Markets and 50 Country Markets Forecasted to 2024)

    Published: October 28, 2019 | Price: $4,000.00 – $8,000.00

    The Global Market for Medical Devices, 10th edition, provides a comprehensive view of the medical device market and opportunity for medical device manufacturers, competitors, and investors. The report examines the companies in the market, the types of devices sold across the global market, and the country markets they are sold in. As part of its coverage, this report contains market sizing and forecasts for the world medical device market and the medical device markets of 50 countries, providing the following...
    The World Market for HbA1c Tests

    Published: October 17, 2019 | Price: $5,000.00 – $10,000.00

    Given its effectiveness in detecting and monitoring treatment of diabetes, HbA1c has become a high-growth and highly competitive market in IVD testing. Globally, a growing amount of dollars is being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c tests. A major contributing factor to growth is the growing availability of HbA1c testing both at the professional level and at the self-testing level. Kalorama’s...
    IVD Test Procedure Volumes, 2019-2024

    Published: October 11, 2019 | Price: $5,000.00 – $10,000.00

    In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of the both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD...
    The Market for Artificial Intelligence (AI) in Healthcare

    Published: September 27, 2019 | Price: $5,000.00 – $10,000.00

    Issues facing the healthcare industry are challenging and complex, including staff reductions, increased service demands and funding cuts. It is not surprising then that many are looking to the advanced solutions that artificial intelligence (AI) can offer in this realm. Kalorama Information's report, The Market for Artificial Intelligence (AI) in Healthcare, quantifies the opportunity and future market opportunity for AI in healthcare, already an almost two-billion-dollar market, with applications in workflow and population health, drug discovery and emerging applications in...
    Internet of Things (IoT) in Healthcare

    Published: September 19, 2019 | Price: $5,000.00 – $10,000.00

    By 2020, it is estimated that there will be 21 billion connected devices in the world. That will be five times as many as just four years ago. This fact affects healthcare as much as any industry. Internet of Things (IoT) in Healthcare tracks the trends around IoT in healthcare and makes specific market estimates and forecasts. The industry adoption of technology in healthcare is driven by an increase in government mandates, staffing shortages, improving clinical outcomes, and increasing pressures...
    The Market for Urgent Care Centers

    Published: August 6, 2019 | Price: $3,000.00 – $6,000.00

    With a demand in healthcare to lower unneeded emergency room visits and provide more options for patients, more and more customers will seek urgent care in the coming years.  This report will provide marketers and business planners with the important data they need on this emerging channel of business.  Kalorama has covered the urgent care trend with estimates of its impact on IVD and imaging since 2013. This Kalorama Information report, The Market for Urgent Care Centers, is a detailed...
    The Market for Next-Generation Sequencing and Kalorama Survey of NGS Laboratories

    Published: August 2, 2019 | Price: $6,000.00 – $12,000.00

    Next-generation sequencing (NGS) technologies encompass the modern, post-Sanger sequencing techniques that revolutionized and expanded the fields of molecular biology and genomics in recent years. NGS has been a disruptive technology that had a substantial impact on the characterization of the genome of various species, and has found numerous applications in a large variety of fields, including clinical diagnostics, drug discovery and development, agriculture, and forensics. Next-Generation Sequencing Markets provides an in-depth look at the sequencing market, including data for 2018-2023...
    The Worldwide Market for In Vitro Diagnostic Tests: 12th Edition

    Published: August 2, 2019 | Price: $8,000.00 – $16,000.00

    Now in its 12th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. The 2,000-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market. 2000-Page Report Based on Vendor Reporting, Interviews, Vendor Activities Authored by Veteran IVD Analysts with Industry Knowledge 12 Detailed Market Chapters with 2019 Market Estimate Where is IVD Heading? –  Market Segment...
    The World Market for Biomarkers (Cardiac Markers [cTn, HscTn, Acute CK-MB/BNP, Others], Tumor Markers [PSA, CEA, CA 125, AFP, PSA Rapid, Others], Coagulation Markers [PT/INR, D-dimer], Infectious Disease Markers [by Disease], Immunological Disease Markers [Autoimmune/Allergy], Neurological Markers, C-Reactive Protein and Other Markers)

    Published: July 23, 2019 | Price: $5,000.00 – $10,000.00

    Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2014 to 2024, with 2019...
    Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)

    Published: July 23, 2019 | Price: $4,500.00 – $9,000.00

    Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts. Test Segments: Market Sizing and Forecasts There are several segments where testing at the molecular level has thrived, including the following: • HPV Testing • CT/NG Testing • Molecular Hepatitis Testing • HIV Testing...
    Understanding the Clinical Diagnostics Customer Experience: Results of the 2019 Kalorama Survey of Laboratories

    Published: July 19, 2019 | Price: $6,500.00

      Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price.  This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. Kalorama conducted a 2019 survey of laboratory instrument users in the United States, Canada and Europe (included in respondents are lab managers, lab directors,...
    Mergers and Acquisitions in the IVD Market

    Published: June 28, 2019 | Price: $2,000.00 – $4,000.00

    In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. In this environment, companies are making strategic acquisitions that simultaneously add a revenue stream and product innovation. Kalorama Information looks at these market transactions in Mergers and Acquisitions in the IVD Market, recording more than 220 acquisitions in the diagnostics...
    The World Molecular Diagnostics Market, 8th Edition

    Published: June 6, 2019 | Price: $4,000.00 – $8,000.00

    Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and...
    Syndromic Testing Markets

    Published: May 30, 2019 | Price: $2,500.00 – $5,000.00

    Saving sample volume, cutting down provider time, reducing costs, improving outcomes, these are goals of the healthcare system, and they are well suited to a test that can identify more than a single pathogen. It has been thought that numerous pathogens tested directly from clinical specimens could change up diagnostics, and many vendors have responded by producing syndromic multiplex panels with considerable capabilities. These single tests, designed to detect a number of organisms that might have caused a particular syndrome,...
    The World Liquid Biopsy Market

    Published: May 30, 2019 | Price: $5,500.00 – $11,000.00

    Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. This report, The World Liquid Biopsy Market, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid...
    Remote Patient Monitoring and Telehealth Market

    Published: May 23, 2019 | Price: $5,500.00 – $11,000.00

    Remote Patient Monitoring and Telehealth Market represents Kalorama Information’s 11th edition of coverage of the advanced remote patient monitoring market, reflecting the market’s increasing focus on telehealth and telemedicine. The global patient monitoring and telehealth market has continued its expansion in both the institutional and home segments of the health market, with the United States and many European countries at the forefront of implementation. Telehealth is becoming an integrated part of how health is delivered worldwide. The market has benefited...
    IVD Market Report Bundle: Worldwide Market 11th Edition & 2019 Market Trends Summary

    Published: May 16, 2019 | Price: $8,400.00 – $16,800.00

    Comprehensive coverage of the IVD Market including the Worldwide Market Report (11th edition) and the 2019 IVD Market Trends Summary   Bundle and save 20% over buying these reports individually!   The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition This Kalorama Information report represents the 11th edition of this comprehensive look at the IVD industry.   At 1,800 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market.  It also profiles...
    Biosimilar Market Trends 2019

    Published: May 8, 2019 | Price: $3,000.00 – $6,000.00

    Biopharmaceuticals are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies, and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed to provide a snapshot of issues and trends that are affecting the biosimilar market...
    Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other

    Published: April 30, 2019 | Price: $5,500.00 – $11,000.00

    Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Most of the leading industry competitors as well as a sizable number of specialized IVD concerns are active in this product segment. The detection and characterization of infectious diseases hold promising worldwide growth potential as discussed in Kalorama’s Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other. The World Infectious Disease Testing Market...
    Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics)

    Published: April 26, 2019 | Price: $4,500.00 – $9,000.00

    Sexually transmitted diseases (STDs) are a major public health issue. There occur approximately 550 million new STDs annually worldwide. In the US, there are more than 35 million each year. Sexually Transmitted Disease (STD) Testing Markets (Test Services, Diagnostics) analyzes the current and potential world market from 2018 to 2023 for tests and systems used to diagnose STDs. The key STDs and diagnostics covered in the report are the following: Chlamydia Gonorrhea Syphilis Human Papillomavirus (HPV) Human immunodeficiency viruses (HIV) Herpes simplex...
    IVD Market Trends Summary

    Published: April 26, 2019 | Price: $3,000.00 – $6,000.00

    In vitro diagnostic (IVD) products continue to see positive sales growth in many categories, while others mature. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. IVD Market Trends Summary features current trends and updates in the worldwide IVD market. Highlights of these updates include: Market developments in developing markets – Latin America, the Middle East and Eastern Europe Effects of PAMA in...
    EMR 2019: The Market for Electronic Medical Records

    Published: April 23, 2019 | Price: $5,000.00 – $10,000.00

    EMR 2019 represents the twelfth time that Kalorama Information has created a detailed study of the electronic medical records (EMR) industry. The report looks at the market and trends affecting electronic medical record software and related services. Included in the report are statistics influencing the industry, demographics, life expectancy, and company strategies. This 450-page report is a complete global analysis of the EMR / EHR market. A market summary includes a total market analysis, including: EMR Market Analysis 2018-2023 ($...
    The 2019 Worldwide Market for Targeted Cancer Therapeutics

    Published: April 16, 2019 | Price: $5,000.00 – $10,000.00

    Kalorama Information has watched the cancer treatment market evolve over the past two decades and evaluated the impact new technologies are making on the market. The 2019 Worldwide Market for Targeted Cancer Therapeutics focuses on the expanding area of targeted therapies and includes current products available and discusses some of the most exciting developments in progress.  This report covers targeted cancer therapies that do at least one of the following: Block or turn off chemical signals that tell the cancer...
    Out-of-Pocket Healthcare Expenditures in the United States

    Published: April 2, 2019 | Price: $4,000.00 – $8,000.00

    A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type, by...
    The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)

    Published: March 27, 2019 | Price: $5,000.00 – $10,000.00

    Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and, most recently, convenience clinics. Kalorama’s Worldwide Market...
    Clinical Laboratory Services Market

    Published: March 8, 2019 | Price: $5,000.00 – $10,000.00

    Clinical laboratories are an essential part of the health industry. It is estimated that between 70% - 80% of physicians’ diagnoses are a result of laboratory tests. In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons. Clinical Laboratory Services Market provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence...